Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- Uo
Lists including Nathan
Work Experience
2024
Co-Founder
2024
2019
Consultant
2024
Analyst
2022 - 2024
Nate Davis is an Analyst on the Investment Team at RA Capital Management. Nate conducts due diligence on biotechnology companies at RA Capital and serves as a Board Director for The Covid Apollo Project and Nucleix. Previously, Nate worked closely with the Investment Team, as a Senior Associate within the TechAtlas division, to originate conviction in potential investments by identifying breakthroughs and putting data into context. Prior to RA Capital, Nate worked as an Investment Analyst at Wolfram Ventures. Nate has a BS in Biological Sciences from University of Vermont.
Associate
2019 - 2022
I am an Associate with the TechAtlas division of RA Capital Management. My primary responsibility is to create competitive landscapes of drugs and medical devices for disease indications and capabilities.
2021 - 2024
Board Observer
2021 - 2024
2021 - 2024
Board Observer
2021 - 2024
2021 - 2024
Board Member
2021 - 2024
2021 - 2023
Executive Chair
2021 - 2023
2021 - 2022
Board Observer
2021 - 2022
2021 - 2022
Board Observer
2021 - 2022
2021 - 2021
Board Observer
2021 - 2021
2018 - 2019
MassConnect Mentor
2018 - 2019